Skip to main content

Table 4 Clinical characteristics of patients with PTAAB (n = 17)

From: Prophylactic temporary abdominal aortic balloon occlusion for patients with pernicious placenta previa: a retrospective study

  GroupC (n = 5) GroupD (n = 12) P value
Estimated blood loss (ml) 1740.00 ± 750.33 3762.50 ± 3728.33 0.096
Total transfusion (ml) 3130.00 ± 1159.52 6484.33 ± 4711.29 0.143
Red blood cell transfusion(u) 2.80 ± 2.68 10.66 ± 11.97 0.038#
Blood plasma transfusion (ml) 280.00 ± 268.32 1033.33 ± 1098.20 0.044#
Platelet transfusion(u) 0.00 ± 0.00 0.58 ± 1.16 0.289
Fibrinogen transfusion(g) 0.00 ± .0.00 2.04 ± 3.22 0.082
Prothrombin complex transfusion(u/100) 0.00 ± .0.00 4.00 ± 7.23 0.802
Postoperative hospital stay (day) 6.80 ± 2.95 8.25 ± 5.37 0.583
Preoperative hemoglobin(g/L) 116.80 ± 14.75 112.50 ± 13.77 0.594
Preoperative creatine (umol/L) 47.80 ± 3.19 53.08 ± 14.94 0.454
Preoperative urea nitrogen (mmol/L) 3.57 ± 1.33 3.36 ± 0.97 0.726
Postoperative hemoglobin at 24 h(g/L) 100.00 ± 25.52 99.17 ± 16.19 0.932
Postoperative creatine at 24 h (umol/L) 58.60 ± 24.37 59.25 ± 25.01 0.961
Postoperative urea nitrogen at 24 h (mmol/L) 3.07 ± 1.22 3.16 ± 1.54 0.912
Spinal anesthesia 2 (11.8%) 6 (50%) 0.080
Preoperative ureteral stent placement 5 (100%) 7 (58.3%) 0.245
  1. PTAAB prophylactic temporary abdominal aortic balloon
  2. #p-value less than 0.05 was considered statistically significant